Intelligence Platform

Patents

Browse 812 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 9605055

Anti-CD100 antibodies and methods of using the same

VACCINEX, INC. · Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9598495

Use of semaphorin-4D binding molecules for treating neurodegenerative disorders

VACCINEX, INC. · Granted Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9566329

Live, attenuated rubella vector to express vaccine antigens

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9566320

Mucin-associated surface protein as vaccine against Chagas disease

The Board of Regents of the University of Texas System · Granted Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9555090

Equine encephalitis virus vaccines and methods of using thereof

The United States of America as repesented by the Secretary of Army, on behalf of the U.S. Army Medical Research Institute of Infections Diseases · Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9555100

Herpes virus vaccine and methods of use

The Regents of the University of California · Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9555099

Vaccines for HSV-2

IMMUNE DESIGN CORP. · Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9528094

Attenuated African swine fever virus vaccine based in the deletion of MGF genes

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9518096

Virus-like particles comprising composite capsid amino acid sequences for enhanced cross r

Takeda Vaccines, Inc. · Granted Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9517262

Vaccine injection, preparation method and use thereof

CHINA 302 MILITARY HOSPITAL OF PLA · Granted Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9512224

Use of semaphorin-4D binding molecules for treatment of atherosclerosis

VACCINEX, INC. · Granted Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9498526

Human rotavirus vaccine strains and diagnostics

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9492523

Broadly protective Shigella vaccine based on type III secretion apparatus proteins

The Board of Regents for Oklahoma State University · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9486518

Membrane proximal region of HIV GP41 anchored to the lipid layer of a virus-like particle

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9474796

Crimean-Congo hemorrhagic fever virus vaccine

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9474795

Polysaccharide-protein conjugate vaccines

granted patent

US 9474793

Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and hepatitis B

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9446112

Clostridium difficile DNA vaccine

Inovio Pharmaceuticals, Inc. · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9446114

Cross-protective arenavirus vaccines and their method of use

Inovio Pharmaceuticals, Inc. · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9439959

Chimeric influenza virus-like particles

Takeda Vaccines, Inc. · Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9439960

Cytomegalovirus vaccines and methods of production

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9441019

Influenza hemagglutinin protein-based vaccines

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9422347

Algal produced malarial transmission blocking vaccines

The Regents of the University of California · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9415099

Method of altering the immundominance hierarchy of HIV gag by DNA vaccine expressing conse

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted